Immune thrombocytopenia (ITP) is commonly encountered in clinical practice. In 1996 the
American Society of Hematology published a landmark guidance paper designed to assist …

Previously published guidelines for the diagnosis and management of primary immune
thrombocytopenia (ITP) require updating largely due to the introduction of new classes of …

Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …

Immune thrombocytopenic purpura, which may lead to bleeding, is typically caused by
antibodies directed against the platelet glycoprotein IIb/IIIa complex. Since the management …

The Rh blood group system is one of the most polymorphic and immunogenic systems
known in humans. In the past decade, intense investigation has yielded considerable …

Background Chronic immune thrombocytopenic purpura (ITP) is characterised by
accelerated platelet destruction and decreased platelet production. Short-term …

METHODS MedLine was searched via PubMed using the following criteria:'
thrombocytopenia','platelet count', autoimmune thrombocytopenic purpura¢,'ITP',' …

Chronic immune thrombocytopenic purpura (ITP) is characterized by low platelet counts and
mucocutaneous bleeding. In previous studies romiplostim (AMG531), a thrombopoiesis …

The paradigm for managing primary immune thrombocytopenia (ITP) in adults has changed
with the advent of rituximab and thrombopoietin receptor agonists (TPO-RAs) as options for …

Our goal is to set forth our opinion of the best approach to managing adults with primary
idiopathic (autoimmune) thrombocytopenic purpura (ITP), with emphasis on the word …